The Feasibility of Blood Borne Virus Testing in Inner-City Emergency Departments

Cieply, L.; Ijaz, Samreen; Kara, Ertuğrul; Rodger, A; Rosenberg, William; Mbisa, Jean L.; Mandal, Subinay; Lattimore, Sam

doi:10.1016/s0168-8278(16)01723-2

Cited by 1 publication

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We identified 14 seroprevalence studies in populations attending and testing in EDs [12–25] (Figure 2); most were on HIV testing in the USA (see Appendix S2 for further details of the studies), and test positivity in 54 studies within the USA, Canada and Europe, most focused on HIV (see Appendix S2 for further details of the studies) [21, 25–77].…”

Section: Resultsmentioning

confidence: 99%

“…One of the major considerations for assessing whether EDs are an appropriate setting for BBV testing is the seroprevalence in the population attending [12,13,15,[17][18][19][22][23][24]. In the small number of UK studies, mainly in urban areas, higher BBV seroprevalence estimates than the UK general population were found, suggesting that when considering introducing BBV testing in the ED, the population profile of the catchment area, such as ethnic diversity, immigration patterns, levels of deprivation and levels of injecting drug use should be factored in.…”

Section: Discussionmentioning

confidence: 99%

“…Four out of the nine studies that had HCV results had prevalence estimates higher than the recommended level for universal testing by NICE (5.0%), and for HIV, all studies had a result higher than the WHO-recommended level for universal testing (0.2%). Four studies were UK-based, with the BBV prevalence estimates in the ED higher than the estimated UK background population prevalence of 0.4% for HCV, 0.4% for HBV and 0.16% for HIV [13,14,23,25]. One study within the UK [14] identified previous diagnoses prior to unlinking samples, with the undiagnosed prevalence rates for HCV of 0.7%, for HBV of 0.8% and for HIV of 0.3%.…”

Section: Prevalence and Test Positivity Of Bbv In People Attending Edsmentioning

confidence: 99%

See 2 more Smart Citations

Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care

Simmons

Plunkett²,

Cieply³

et al. 2022

HIV Medicine

View full text Add to dashboard Cite

Background: Blood-borne viruses (BBVs) cause significant morbidity and mortality worldwide. Emergency departments (EDs) offer a point of contact for groups at increased risk of BBVs who may be less likely to engage with primary care. We reviewed the literature to evaluate whether BBV testing in this setting might be a viable option to increase case finding and linkage to care.Methods: We searched PubMed database for English language articles published until June 2019 on BBV testing in EDs. Studies reporting seroprevalence surveys, feasibility, linkage to care, enablers and barriers to testing were included. Additional searches for grey literature were performed. Results: Eight-nine articles met inclusion criteria, of which 14 reported BBV seroprevalence surveys in EDs, 54 investigated feasibility and acceptability, and 36 investigated linkage to care. Most studies were HIV-focused and conducted in the USA. Seroprevalence rates were in the range 1.5-17% for HCV, 0.7-1.6% for HBV, and 0.8-13% for HIV. For studies that used an opt-in study design, testing uptake ranged from 2% to 98% and for opt-out it ranged from 16% to 91%. There was a wide range of yield: 13-100% of patients received their test result, 21-100% were linked to care, and 50-91% were retained in care.Compared with individuals diagnosed with HIV, linkage to and retention in care were lower for those diagnosed with hepatitis C. Predictors of linkage to care was associated with certain patient characteristics.Conclusions: Universal opt-out BBV testing in EDs may be feasible and acceptable, but linkage to care needs to be improved by optimizing implementation. Further economic evaluations of hepatitis testing in EDs are needed.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Prevalence and Test Positivity Of Bbv In People Attending Edsmentioning

confidence: 99%

See 1 more Smart Citation

Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care

Simmons

Plunkett²,

Cieply³

et al. 2022

HIV Medicine

View full text Add to dashboard Cite

show abstract

The Feasibility of Blood Borne Virus Testing in Inner-City Emergency Departments

Cited by 1 publication

References 0 publications

Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care

Blood‐borne virus testing in emergency departments – a systematic review of seroprevalence, feasibility, acceptability and linkage to care

Contact Info

Product

Resources

About